Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine
NCT03677115Phase 4Withdrawn
- Sponsor
- China Medical University
- Start
- Nov 2018
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in postoperative pain, sponsored by China Medical University. Primary endpoint: Change of analgesia duration at 3 days. Planned start Nov 2018; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03677115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677115.